Protekt Therapeutics
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Protekt Therapeutics
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.